Condition

Non-Small Cell Lung Carcinoma clinical trials and research

• 10Clinical trials
• 33Countries

Newest Non-Small Cell Lung Carcinoma clinical trials

All recruiting trials (10)

• Amivantamab with platinum chemotherapy for metastatic EGFR‑mutant non‑small cell lung cancer

  This study will try giving amivantamab together with platinum chemotherapy to adults with metastatic NSCLC who have specific EGFR mutations to see how long their cancer stays controlled and how safe the treatment is.

  Recruiting at 11 sites Groupe Francais De Pneumo-Cancerologie · Aix-en-Provence and 15 other locations · NCT07563205

• PLX-61639 for advanced SMARCA4-deficient solid tumors

  This trial will test a daily oral drug called PLX-61639 in people with advanced or metastatic solid tumors that have a SMARCA4 loss and who have no other approved treatment options.

  Recruiting at 10 sites Phase 1 Plexium, Inc. · Scottsdale, Arizona and 9 other locations · NCT07284186

• Retifanlimab plus ruxolitinib for advanced kidney and lung cancers

  This trial will test whether taking ruxolitinib twice daily together with retifanlimab infusions every 4 weeks is safe and can help people with metastatic renal cell carcinoma or non-small cell lung cancer who progressed on prior PD-1/PD-L1 therapy.

  Recruiting Phase 1/2 University of California, San Diego · La Jolla, California · NCT07219576

• PF-08046054 (SGN-PDL1V) versus docetaxel for PD-L1–positive advanced non-small cell lung cancer

  This test compares PF-08046054 (SGN-PDL1V) with docetaxel for adults whose PD-L1–positive advanced NSCLC progressed after PD-1/PD-L1 inhibitors, platinum chemotherapy, and targeted treatments when appropriate.

  Recruiting at 454 sites Phase 3 Pfizer · Alabaster, Alabama and 468 other locations · NCT07144280

• Evaluating a new treatment for advanced non-squamous lung cancer

  This study is testing a new combination of medications for adults with advanced lung cancer who haven't had treatment before, to see if it is safe and effective.

  Recruiting at 123 sites Phase 1/2 AbbVie · Phoenix, Arizona and 126 other locations · NCT06772623

• Using PET/CT to Measure HER3 Levels in Lung Cancer Patients

  This study is testing a new imaging method to see how much of a specific protein called HER3 is in lung cancer patients who have already been treated, to help figure out who might benefit from a new drug.

  Recruiting Phase 2 The Netherlands Cancer Institute · Amsterdam, North Holland · NCT06222489

• Observational study on the use of Tabrecta® for lung cancer in South Korea

  This study is testing how safe and effective Tabrecta® is for people with non-small-cell lung cancer in South Korea in real-life situations.

  Recruiting at 10 sites Novartis · Daegu, Dalseo gu and 9 other locations · NCT05703516

• Exploring the gut microbiome's role in cancer treatment response

  This study is testing how the bacteria in the gut might affect how well cancer patients respond to a specific type of treatment called immune checkpoint inhibitors.

  Recruiting VastBiome · Elizabethtown, Kentucky · NCT05037825

• Assessing Furmonertinib for Non-small Cell Lung Cancer After Surgery

  This study is testing if a new drug called Furmonertinib can help people with stage II-IIIA non-small cell lung cancer feel better after their surgery compared to a placebo.

  Recruiting Phase 3 Allist Pharmaceuticals, Inc. · Suzhou, Jiangsu · NCT04853342

• Evaluating PC14586 for advanced solid tumors with a specific mutation

  This study is testing a new oral medication called PC14586 to see if it can help people with advanced solid tumors that have a specific mutation in the TP53 gene.

  Recruiting at 71 sites Phase 1/2 PMV Pharmaceuticals, Inc · Irvine, California and 75 other locations · NCT04585750

Related topics

Quick answers

How many Non-Small Cell Lung Carcinoma clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 33 countries. The most sites are in United States (6 trials), France (4 trials), China (3 trials), Australia (3 trials), Germany (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 3: 2, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →